Effect of Azithromycin on Systemic Markers of Inflammation in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa

BACKGROUND: While the mechanism of action by which azithromycin exerts positive effects in patients with cystic fibrosis remains unclear, evidence suggests that azithromycin may act as an immunomodulatory agent. We examined changes in systemic inflammatory markers in a double-blind, randomized, cont...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ratjen, Felix, Saiman, Lisa, Mayer-Hamblett, Nicole, Lands, Larry C., Kloster, Margaret, Thompson, Valeria, Emmett, Peggy, Marshall, Bruce, Accurso, Frank, Sagel, Scott, Anstead, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Chest Physicians 2012
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3610595/
https://ncbi.nlm.nih.gov/pubmed/22595153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.12-0628
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados